These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19506297)

  • 21. Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis.
    Raggi C; Luciani A; Nevo N; Antignac C; Terryn S; Devuyst O
    Hum Mol Genet; 2014 May; 23(9):2266-78. PubMed ID: 24319100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ocular anomalies in a cystinosis animal model mimic disease pathogenesis.
    Kalatzis V; Serratrice N; Hippert C; Payet O; Arndt C; Cazevieille C; Maurice T; Hamel C; Malecaze F; Antignac C; Müller A; Kremer EJ
    Pediatr Res; 2007 Aug; 62(2):156-62. PubMed ID: 17597652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-cut diagnostic tool in cystinosis: Bone marrow aspiration.
    Sürmeli Döven S; Delibaş A; Kayacan UR; Ünal S
    Pediatr Int; 2017 Nov; 59(11):1178-1182. PubMed ID: 28871612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of Cystinotic Mice by Kidney-Specific Megalin Ablation Supports an Endocytosis-Based Mechanism for Nephropathic Cystinosis Progression.
    Janssens V; Gaide Chevronnay HP; Marie S; Vincent MF; Van Der Smissen P; Nevo N; Vainio S; Nielsen R; Christensen EI; Jouret F; Antignac C; Pierreux CE; Courtoy PJ
    J Am Soc Nephrol; 2019 Nov; 30(11):2177-2190. PubMed ID: 31548351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief reports: Lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes.
    Naphade S; Sharma J; Gaide Chevronnay HP; Shook MA; Yeagy BA; Rocca CJ; Ur SN; Lau AJ; Courtoy PJ; Cherqui S
    Stem Cells; 2015 Jan; 33(1):301-9. PubMed ID: 25186209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal phenotype of the cystinosis mouse model is dependent upon genetic background.
    Nevo N; Chol M; Bailleux A; Kalatzis V; Morisset L; Devuyst O; Gubler MC; Antignac C
    Nephrol Dial Transplant; 2010 Apr; 25(4):1059-66. PubMed ID: 19846395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of long-term cysteamine treatment in patients with cystinosis.
    Ariceta G; Giordano V; Santos F
    Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystinosis: a review.
    Elmonem MA; Veys KR; Soliman NA; van Dyck M; van den Heuvel LP; Levtchenko E
    Orphanet J Rare Dis; 2016 Apr; 11():47. PubMed ID: 27102039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteamine therapy: a treatment for cystinosis, not a cure.
    Cherqui S
    Kidney Int; 2012 Jan; 81(2):127-9. PubMed ID: 22205430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations.
    Anikster Y; Lucero C; Guo J; Huizing M; Shotelersuk V; Bernardini I; McDowell G; Iwata F; Kaiser-Kupfer MI; Jaffe R; Thoene J; Schneider JA; Gahl WA
    Pediatr Res; 2000 Jan; 47(1):17-23. PubMed ID: 10625078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis.
    Brasell EJ; Chu L; El Kares R; Seo JH; Loesch R; Iglesias DM; Goodyer P
    Pediatr Nephrol; 2019 May; 34(5):873-881. PubMed ID: 30413946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystinosis (ctns) zebrafish mutant shows pronephric glomerular and tubular dysfunction.
    Elmonem MA; Khalil R; Khodaparast L; Khodaparast L; Arcolino FO; Morgan J; Pastore A; Tylzanowski P; Ny A; Lowe M; de Witte PA; Baelde HJ; van den Heuvel LP; Levtchenko E
    Sci Rep; 2017 Feb; 7():42583. PubMed ID: 28198397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystine accumulation in the CNS results in severe age-related memory deficits.
    Maurice T; Hippert C; Serratrice N; Dubois G; Jacquet C; Antignac C; Kremer EJ; Kalatzis V
    Neurobiol Aging; 2009 Jun; 30(6):987-1000. PubMed ID: 17977621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.
    Cherqui S; Courtoy PJ
    Nat Rev Nephrol; 2017 Feb; 13(2):115-131. PubMed ID: 27990015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin.
    Attard M; Jean G; Forestier L; Cherqui S; van't Hoff W; Broyer M; Antignac C; Town M
    Hum Mol Genet; 1999 Dec; 8(13):2507-14. PubMed ID: 10556299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of ocular cystinosis associated with two potentially severe CTNS mutations.
    Browning AC; Figueiredo GS; Baylis O; Montgomery E; Beesley C; Molinari E; Figueiredo FC; Sayer JA
    Ophthalmic Genet; 2019 Apr; 40(2):157-160. PubMed ID: 30957593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteamine treatment restores the in vitro ability to differentiate along the osteoblastic lineage of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient.
    Conforti A; Taranta A; Biagini S; Starc N; Pitisci A; Bellomo F; Cirillo V; Locatelli F; Bernardo ME; Emma F
    J Transl Med; 2015 May; 13():143. PubMed ID: 25947233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2A.
    Zhang J; Johnson JL; He J; Napolitano G; Ramadass M; Rocca C; Kiosses WB; Bucci C; Xin Q; Gavathiotis E; Cuervo AM; Cherqui S; Catz SD
    J Biol Chem; 2017 Jun; 292(25):10328-10346. PubMed ID: 28465352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancytopenia in a patient with cystinosis secondary to myelosuppression from cystine crystal deposition: a case report.
    Lyou Y; Zhao X; Nangia CS
    J Med Case Rep; 2015 Sep; 9():205. PubMed ID: 26377065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
    Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
    Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.